285 related articles for article (PubMed ID: 33441913)
21. A comprehensive approach to developing a multi-epitope vaccine against
Jiang F; Han Y; Liu Y; Xue Y; Cheng P; Xiao L; Gong W
Front Immunol; 2023; 14():1280299. PubMed ID: 38022558
[TBL] [Abstract][Full Text] [Related]
22. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
Jalal K; Khan K; Uddin R
Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
[TBL] [Abstract][Full Text] [Related]
23. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
24. Computational vaccinology guided design of multi-epitopes subunit vaccine designing against Hantaan virus and its validation through immune simulations.
Ghafoor D; Kousar A; Ahmed W; Khan S; Ullah Z; Ullah N; Khan S; Ahmed S; Khan Z; Riaz R
Infect Genet Evol; 2021 Sep; 93():104950. PubMed ID: 34089911
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive screening of the whole proteome of hantavirus and designing a multi-epitope subunit vaccine for cross-protection against hantavirus: Structural vaccinology and immunoinformatics study.
Abdulla F; Nain Z; Hossain MM; Syed SB; Ahmed Khan MS; Adhikari UK
Microb Pathog; 2021 Jan; 150():104705. PubMed ID: 33352214
[TBL] [Abstract][Full Text] [Related]
26. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
27. Computational Identification and Characterization of a Promiscuous T-Cell Epitope on the Extracellular Protein 85B of
Hossain MS; Azad AK; Chowdhury PA; Wakayama M
Biomed Res Int; 2017; 2017():4826030. PubMed ID: 28401156
[TBL] [Abstract][Full Text] [Related]
28. Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.
Jeyanathan M; Damjanovic D; Yao Y; Bramson J; Smaill F; Xing Z
J Infect Dis; 2016 Dec; 214(12):1996-2005. PubMed ID: 27703038
[TBL] [Abstract][Full Text] [Related]
29. Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains.
Shafaghi M; Bahadori Z; Madanchi H; Ranjbar MM; Shabani AA; Mousavi SF
BMC Bioinformatics; 2023 Feb; 24(1):67. PubMed ID: 36829109
[TBL] [Abstract][Full Text] [Related]
30. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
31. Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics.
Zhu F; Tan C; Li C; Ma S; Wen H; Yang H; Rao M; Zhang P; Peng W; Cui Y; Chen J; Pan P
Front Immunol; 2023; 14():1100188. PubMed ID: 36845087
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Immuno-Informatic Approach to Design a Multiepitope-Based Vaccine Against Emerging Multiple Drug Resistant
Damas MSF; Mazur FG; Freire CCM; da Cunha AF; Pranchevicius MDS
Front Immunol; 2022; 13():768569. PubMed ID: 35371033
[No Abstract] [Full Text] [Related]
33. Development a multi-epitope driven subunit vaccine for immune response reinforcement against Serogroup B of Neisseria meningitidis using comprehensive immunoinformatics approaches.
Rostamtabar M; Rahmani A; Baee M; Karkhah A; Prajapati VK; Ebrahimpour S; Nouri HR
Infect Genet Evol; 2019 Nov; 75():103992. PubMed ID: 31394292
[TBL] [Abstract][Full Text] [Related]
34. Computational discovery and ex-vivo validation study of novel antigenic vaccine candidates against tuberculosis.
Arega AM; Pattanaik KP; Nayak S; Mahapatra RK
Acta Trop; 2021 May; 217():105870. PubMed ID: 33636152
[TBL] [Abstract][Full Text] [Related]
35. In silico design of a multi-epitope vaccine against HPV16/18.
Sanami S; Rafieian-Kopaei M; Dehkordi KA; Pazoki-Toroudi H; Azadegan-Dehkordi F; Mobini GR; Alizadeh M; Nezhad MS; Ghasemi-Dehnoo M; Bagheri N
BMC Bioinformatics; 2022 Aug; 23(1):311. PubMed ID: 35918631
[TBL] [Abstract][Full Text] [Related]
36. Exploring T & B-cell epitopes and designing multi-epitope subunit vaccine targeting integration step of HIV-1 lifecycle using immunoinformatics approach.
Abdulla F; Adhikari UK; Uddin MK
Microb Pathog; 2019 Dec; 137():103791. PubMed ID: 31606417
[TBL] [Abstract][Full Text] [Related]
37. Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against
Kumar A; Sharma P; Arun A; Meena LS
J Biomol Struct Dyn; 2023 May; 41(8):3382-3404. PubMed ID: 35293852
[TBL] [Abstract][Full Text] [Related]
38. Multi epitope vaccine candidate design against
Devarakonda Y; Reddy MVNJ; Neethu RS; Chandran A; Syal K
J Biomol Struct Dyn; 2023; 41(22):12654-12667. PubMed ID: 36636838
[No Abstract] [Full Text] [Related]
39. Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.
Medha ; Priyanka ; Sharma S; Sharma M
Eur J Pharm Sci; 2022 Jan; 168():106051. PubMed ID: 34744006
[TBL] [Abstract][Full Text] [Related]
40. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
